UroGen Pharma
URGN | NASDAQ
$28.10
+$1.92 (+7.33%)
At close: Nov 16, 2026, 4:00 PM ET
$28.18
+$0.08 (+0.28%)
Pre-market:
Nov 17, 2026, 4:01 AM ET
UroGen Pharma Institutional Ownership
Institutional ownership explainedInstitutional Ownership
Net OutflowTotal Institutions
199
Total Ownership
84.47%
Capital Flow
-$730.1M
Shares Change
-3.89M
Ownership Distribution
Institutions (84.47%)
Others (15.53%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
bullishNew Positions
42
Increased Positions
103
Reduced Positions
54
Closed Positions
23
New (42)
Increased (103)
Reduced (54)
Closed (23)
Options Sentiment & Activity
bullishPut/Call Ratio
0.567
Call Flow
259,400
Put Flow
147,100
Calls (64%)
Puts (36%)
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Rtw Investments, LP | 9.02% -0.39% | 1.43% +75.61% | 4.54M 0.00% | 167.22M +104.67% | |
| Blackrock, Inc. | 6.35% +12.07% | < 0.01% +95.85% | 3.2M +12.51% | 117.81M +130.27% | |
| Morgan Stanley | 5.11% +0.24% | < 0.01% +80.81% | 2.58M +0.64% | 94.81M +105.98% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove URGN